Francesca De Robertis

Lecce, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosis.

A predictive tool for early treatment escalation after initiation of moderate-efficacy therapy in pediatric-onset multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: June 02, 2026

Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry.

Evaluation of drivers of treatment switch in relapsing multiple sclerosis: a study from the Italian MS Registry.

Journal: Journal of neurology

Published: August 08, 2023

Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register.

Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: February 17, 2022

Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register.

Retrospectively acquired cohort study to evaluate the long-term impact of two different treatment strategies on disability outcomes in patients with relapsing multiple sclerosis (RE.LO.DI.MS): data from the Italian MS Register.

Journal: Journal of neurology

Published: July 11, 2019

Copper and ceruloplasmin dyshomeostasis in serum and cerebrospinal fluid of multiple sclerosis subjects.

Copper and ceruloplasmin dyshomeostasis in serum and cerebrospinal fluid of multiple sclerosis subjects.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: January 25, 2018

Metabolic response to glatiramer acetate therapy in multiple sclerosis patients.

Metabolic response to glatiramer acetate therapy in multiple sclerosis patients.

Journal: BBA clinical

Published: July 25, 2016

Long-term adherence of patients with relapsing-remitting multiple sclerosis to subcutaneous self-injections of interferon β-1a using an electronic device: the RIVER study.

Long-term adherence of patients with relapsing-remitting multiple sclerosis to subcutaneous self-injections of interferon β-1a using an electronic device: the RIVER study.

Journal: Expert opinion on drug delivery

Published: February 25, 2016

Diagnostic Criteria for Psychosomatic Research and Psychosocial Functioning in Multiple Sclerosis.

Diagnostic Criteria for Psychosomatic Research and Psychosocial Functioning in Multiple Sclerosis.

Journal: Psychotherapy and psychosomatics

Published: November 16, 2015

A lipidomic approach to the study of human CD4(+) T lymphocytes in multiple sclerosis.

A lipidomic approach to the study of human CD4(+) T lymphocytes in multiple sclerosis.

Journal: BMC neuroscience

Published: January 31, 2015

Bioenergetics profile of CD4(+) T cells in relapsing remitting multiple sclerosis subjects.

Bioenergetics profile of CD4(+) T cells in relapsing remitting multiple sclerosis subjects.

Journal: Journal of biotechnology

Published: July 11, 2014

ExtaviJect® 30G device for subcutaneous self-injection of interferon beta-1b for multiple sclerosis: a prospective European study.

ExtaviJect® 30G device for subcutaneous self-injection of interferon beta-1b for multiple sclerosis: a prospective European study.

Journal: Medical devices (Auckland, N.Z.)

Published: November 21, 2013

Showing 1-11 of 11

Last Updated: 09/26/2026